Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy. [electronic resource]
Producer: 19960709Description: 520-6 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Bone Marrow Transplantation
- Female
- Graft Enhancement, Immunologic
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Hodgkin Disease -- therapy
- Humans
- Interleukin-3 -- administration & dosage
- Lymphoma, Non-Hodgkin -- therapy
- Male
- Middle Aged
- Recombinant Fusion Proteins -- administration & dosage
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.